Special Issue "Advances and Perspectives in Diagnosis and Treatment Strategies for Bladder Cancer"

A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Genitourinary Oncology".

Deadline for manuscript submissions: 15 January 2023 | Viewed by 53

Special Issue Editors

Dr. Julieta Alexandra Pereira Afonso
E-Mail Website
Guest Editor
1. School of Medicine, University of Minho, 4710-057 Braga, Portugal
2. ICVS/3B's PT Government Associate Laboratory, 4710-057 Braga, Portugal
Interests: bladder cancer; chemoresistance; immunotherapy resistance; cancer metabolism; Warburg effect; monocarboxylate transporters; CD147; tumor microenvironment; cancer-associated fibroblasts
Special Issues, Collections and Topics in MDPI journals
Dr. Maria de Fátima Monginho Baltazar
E-Mail Website
Guest Editor
1. School of Medicine, University of Minho, 4710-057 Braga, Portugal
2. ICVS/3B's PT Government Associate Laboratory, 4710-057 Braga, Portugal
Interests: cancer therapy resistance; cancer metabolism; glucose metabolism; Warburg effect; monocarboxylate transporters; CD147; tumour microenvironment; drug discovery
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Bladder cancer is the tenth most commonly diagnosed malignancy and the thirteenth leading cause of cancer-related death worldwide, and its incidence is gradually increasing. Elevated rates of recurrence and progression in patients with localized disease, and resistance to classical cisplatin-based chemotherapy in patients displaying muscle-invasive and metastatic tumors, make direct and indirect costs of patient care higher than in any other type of cancer. Molecular profiling is definitively altering diagnosis, surveillance and the treatment landscape of bladder cancer. Minimally invasive diagnostic approaches are evolving, and therapeutic options for advanced disease have been expanded with immune checkpoint inhibitors, targeted therapies and antibody drug conjugates. Despite these developments, resistance to classical and novel therapeutics occurs in a considerable proportion of patients, and the challenge of unravelling the underlying mechanistic insights remains. Biomarkers for the proper identification of patients who will better respond to therapy are also being investigated, and new potential therapeutic targets will certainly arise. This Special Issue will highlight recent advances and future perspectives in diagnosis and treatment strategies for bladder cancer, from basic research to clinical applications that ultimately aim to improve diagnosis, monitoring and management of bladder cancer patients. 

You may choose our Joint Special Issue in Cancers.

Dr. Julieta Alexandra Pereira Afonso
Dr. Maria de Fátima Monginho Baltazar
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • bladder cancer
  • non-muscle invasive
  • muscle-invasive
  • diagnosis
  • treatment
  • resistance to treatment
  • biomarkers
  • therapeutic targets

Published Papers

This special issue is now open for submission.
Back to TopTop